Anemia and its relationship to clinical outcome in heart failure

Circulation

Volumn 110, Issue 2, 2004, Pages 149-154

  Anand, Inder ^a   McMurray, John J V ^b   Whitmore, James ^c   Warren, Marshelle ^c   Pham, Anh ^c   McCamish, Mark A ^c,d   Burton, Paul B J ^c  

^a VA MEDICAL CENTER   (United States)

^b WESTERN INFIRMARY   (United Kingdom)

^c AMGEN INC   (United States)

^d Perlegen Sciences Inc   (United States)

Author keywords

Anemia; Heart failure; Morbidity; Mortality; Physiology

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ANEMIA; ARTICLE; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE MASS; HEMOGLOBIN DETERMINATION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEW YORK HEART ASSOCIATION CLASS; NORTH AMERICA; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK;

ANEMIA; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; HEMOGLOBINS; HOSPITALIZATION; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; IMMUNOGLOBULIN G; LIFE TABLES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORGAN SIZE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; RECEPTORS, TUMOR NECROSIS FACTOR; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 3142688226     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000134279.79571.73     Document Type: Article

References (23)

1. Mozaffarian D, Nye R, Levy W. Anemia predicts mortality in severe heart failure: the Prospective Randomized Amlodipine Survival Evaluation (PRAISE). J Am Coll Cardiol. 2003;41:1933-1939.
2. Kosiborod M, Smith GL, Radford MJ, et al. The prognostic importance of anemia in patients with heart failure. Am J Med. 2003;114:112-119.
3. Mancini DM, Katz SD, Lang CC, et al. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003;107:294-299.
4. Androne A-S, Katz SD, Lund L, et al. Hemodilution is common in patients with advanced heart failure. Circulation. 2003;107:226-229.
5. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes. Circulation. 2003;107:223-225.
6. Silverberg DS, Wexler D, Blum M, et al. The effect of correction of anemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant. 2003;18:141-146.
7. Tanner H, Moschovitis G, Kuster GM, et al. The prevalence of anemia in chronic heart failure. Int J Cardiol. 2002;86:115-121.
8. Horwich TB, Fonarow GC, Hamilton MA, et al. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol. 2002;39:1780-1786.
9. McClellan WM, Flanders WD, Langston RD, et al. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol. 2002;13:1928-1936.
10. Lauer MS, Evans JC, Levy D. Prognostic implications of subclinical left ventricular dilation and systolic dysfunction in men free of overt cardiovascular disease (the Framingham Heart Study). Am J Cardiol. 1992;70:1180-1184.
11. Grothues F, Moon JC, Bellenger NG, et al. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J. 2004;147:218-223.
12. Means RT. Recent developments in the anemia of chronic disease. Curr Hematol Rep. 2003;2:116-121.
13. Cromie N, Lee C, Struthers AD. Anaemia in chronic heart failure: what is its frequency in the UK and its underlying causes? Heart. 2002;87:377-378.
14. Plata R, Comejo A, Arratia C, et al. Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial. Lancet. 2002;359:663-666.
15. Mann DL. Stress-activated cytokines and the heart: from adaptation to maladaptation. Annu Rev Physiol. 2003;65:81-101.
16. Anand IS, Chandrasehekhar Y, Ferrari R, et al. Pathogenesis of oedema in chronic severe anemia: studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones. Br Heart J. 1993;70:357-362.
17. Anand IS, Chandrasehekhar Y, Wander GS, et al. Endothelium-derived relaxing factor is important in mediating the high output state in chronic severe anemia. J Am Coll Cardiol. 1995;25:1402-1407.
18. Elhendy A, Modesto KM, Mahoney DW, et al. Prediction of mortality in patients with left ventricular hypertrophy by clinical, exercise stress, and echocardiographic data. J Am Coll Cardiol. 2003;1:129-135.
19. Al-Ahmad A, Rand WM, Manjunath G, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol. 2001;38:955-962.
20. Olivetti G, Lagrasta C, Quaini F, et al. Capillary growth in anemia-induced ventricular wall remodeling in the rat heart. Circ Res. 1989;65:1182-1192.
21. Olivetti G, Quaini F, Lagrasta C, et al. Myocyte cellular hypertrophy and hyperplasia contribute to ventricular wall remodeling in anemia-induced cardiac hypertrophy in rats. Am J Pathol. 1992;141:227-239.
22. Rossi MA, Carillo SV. Electron microscopic study on the cardiac hypertrophy induced by iron deficiency anaemia in the rat. Br J Exp Pathol. 1983;64:373-387.
23. Levin A, Thompson CR, Ethier J, et al. Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin. Am J Kidney Dis. 1999;34:125-134.